
1. Malar J. 2016 Jan 8;15:16. doi: 10.1186/s12936-015-1078-4.

Malaria burden and anti-malarial drug efficacy in Owando, northern Congo.

Singana BP(1), Bogreau H(2)(3)(4)(5), Matondo BD(6), Dossou-Yovo LR(7), Casimiro 
PN(8), Mbouka R(9), Ha Nguyen KY(10)(11)(12), Pradines B(13)(14)(15), Basco
LK(16)(17), Ndounga M(18).

Author information: 
(1)Unité de Recherche sur le Paludisme, Centre d'Etudes sur les Ressources
Végétales (CERVE), BP 1249, Brazzaville, Republic of Congo. bricepembet@yahoo.fr.
(2)Unité de Parasitologie et d'Entomologie, Département des Maladies
Infectieuses, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge,
France. hervebogreau@yahoo.fr.
(3)Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
(URMITE), UM 63, CNRS 7278, IRD 198, Inserm 1095, Aix-Marseille Université,
Marseille, France. hervebogreau@yahoo.fr.
(4)Centre National de Référence du Paludisme région Antilles-Guyane, Laboratoire 
de Parasitologie, Institut Pasteur de la Guyane, Cayenne, France.
hervebogreau@yahoo.fr.
(5)Direction interarmées du service de santé, Cayenne, France.
hervebogreau@yahoo.fr.
(6)Unité de Recherche sur le Paludisme, Centre d'Etudes sur les Ressources
Végétales (CERVE), BP 1249, Brazzaville, Republic of Congo.
brunellematondo@yahoo.fr.
(7)Laboratoire National de Santé Publique (LNSP), BP 120, Brazzaville, Republic
of Congo. doyorel2@gmail.com.
(8)Unité de Recherche sur le Paludisme, Centre d'Etudes sur les Ressources
Végétales (CERVE), BP 1249, Brazzaville, Republic of Congo. pncasimiro@yahoo.fr.
(9)Direction Départementale de la Santé (DDS) de la Cuvette, Owando, Republic of 
Congo. mbouka_rigobert@yahoo.fr.
(10)Unité de Parasitologie et d'Entomologie, Département des Maladies
Infectieuses, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge,
France. hanguyenkimyen@gmail.com.
(11)Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
(URMITE), UM 63, CNRS 7278, IRD 198, Inserm 1095, Aix-Marseille Université,
Marseille, France. hanguyenkimyen@gmail.com.
(12)Centre National de Référence du Paludisme région Antilles-Guyane, Laboratoire
de Parasitologie, Institut Pasteur de la Guyane, Cayenne, France.
hanguyenkimyen@gmail.com.
(13)Unité de Parasitologie et d'Entomologie, Département des Maladies
Infectieuses, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge,
France. bruno.pradines@gmail.com.
(14)Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
(URMITE), UM 63, CNRS 7278, IRD 198, Inserm 1095, Aix-Marseille Université,
Marseille, France. bruno.pradines@gmail.com.
(15)Centre National de Référence du Paludisme, Marseille, France.
bruno.pradines@gmail.com.
(16)Unité de Parasitologie et d'Entomologie, Département des Maladies
Infectieuses, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge,
France. lkbasco@yahoo.fr.
(17)Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes
(URMITE), UM 63, CNRS 7278, IRD 198, Inserm 1095, Aix-Marseille Université,
Marseille, France. lkbasco@yahoo.fr.
(18)Unité de Recherche sur le Paludisme, Centre d'Etudes sur les Ressources
Végétales (CERVE), BP 1249, Brazzaville, Republic of Congo.
ngoualandounga@yahoo.fr.

BACKGROUND: In the Republic of Congo, previous epidemiological studies have only 
been conducted in the south of the country where it is most accessible.
Nationally representative data on the efficacy of new anti-malarial tools are
lacking in the country. As an initial step to close the gap, clinical efficacy of
two artemisinin-based combinations, artesunate-amodiaquine (ASAQ) and
artemether-lumefantrine (AL), was assessed in Owando, a city in equatorial
flooded forest in northern Republic of Congo.
METHODS: Under 12 years old febrile children attending public health facilities
were screened for malaria parasites using lactate dehydrogenase (LDH)-based rapid
diagnostic test (RDT) for malaria and microscopic examination of thick blood
films. Patients with at least 1,000 asexual Plasmodium falciparum parasites/µl of
blood were clinically examined, included after informed consent, and followed up 
for 28 days, according to the 2009 World Health Organization protocol. Patients
were randomly assigned to co-formulated ASAQ (Coarsucam(®)) or AL (Coartem(®))
treatment groups. Plasmodium falciparum recrudescent isolates were compared to
pre-treatment isolates by polymerase chain reaction (PCR) using msp1, msp2, and
glurp genes to distinguish between re-infection and recrudescence.
RESULTS: Between November 2012 and February 2013, 857 under 12 years old febrile 
children were screened, of whom 198 (23.1%) had positive RDT and 167 (19.5%)
positive thick films. ASAQ and AL efficacies were 92.7 and 94.2% before PCR
correction, respectively. After genotyping, the overall efficacy was 100% for
ASAQ and 98.0% for AL.
CONCLUSION: The data reported here represent partially the burden of malaria in
0-11 years old febrile children examined in public health centres of Owando city 
and serve as reference for further studies. Both artemisinin-based combinations
were highly efficacious in patients under 12 years old with acute uncomplicated
malaria. ASAQ was associated with more adverse events, which may reduce
compliance in unsupervised treatment.
TRIAL REGISTRATION: ACTRN12612000940875.

DOI: 10.1186/s12936-015-1078-4 
PMCID: PMC4705584
PMID: 26743431  [Indexed for MEDLINE]

